Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Largest Shareholders Are Private Companies Who Were Rewarded as Market Cap Surged CN¥1.2b Last Week
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Largest Shareholders Are Private Companies Who Were Rewarded as Market Cap Surged CN¥1.2b Last Week
Key Insights
主要见解
- The considerable ownership by private companies in Apeloa PharmaceuticalLtd indicates that they collectively have a greater say in management and business strategy
- A total of 2 investors have a majority stake in the company with 51% ownership
- Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company
- 普洛药业有很多私营公司拥有,这表明它们在管理和业务策略上有更大的发言权。
- 共有2位投资者拥有江苏长青新材料科技51%的所有权。
- 通过分析师预测数据和所有权研究,您可以更好地评估公司未来的业绩。
If you want to know who really controls Apeloa Pharmaceutical Co.,Ltd (SZSE:000739), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are private companies with 51% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
如果你想知道谁真正控制普洛药业(SZSE:000739),那么你需要看一下它的股东注册情况。持有51%股权的私营公司是最大的股东。这意味着,如果股票上涨(或下降),该集团将获得最大的利益(或最大的损失)。
As a result, private companies collectively scored the highest last week as the company hit CN¥17b market cap following a 7.7% gain in the stock.
因此,上周私人公司以CN¥170亿市值成为最高 ,股票上涨7.7%。
Let's delve deeper into each type of owner of Apeloa PharmaceuticalLtd, beginning with the chart below.
让我们深入了解普洛药业的每一种所有者,从下面的图表开始。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240806/0-3cc84e4ff051120e141a83036df80488-0-81b0def0d0a3562e0074c4e61c3d67cf.png/big)
What Does The Institutional Ownership Tell Us About Apeloa PharmaceuticalLtd?
机构持股对普洛药业意味着什么?我们可以看到普洛药业确实有机构投资者;他们持有公司的很大一部分股票。这表明专业投资者中有一定的信誉度。但是,我们不能仅凭这一事实就确定,因为机构有时犯错,就像其他人一样。当多个机构持有一支股票时,存在一种“拥挤交易”的风险。当这样的交易出现问题时,多个方面可能会抢购出售股票。这种风险在没有增长历史的公司中更高。您可以查看普洛药业的历史收入和营业收入,但请记住故事有时并不止如此。
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
机构投资者通常将自己的回报与常见的指数回报进行比较。因此,他们通常会考虑购买包括在相关基准指数中的较大公司。
As you can see, institutional investors have a fair amount of stake in Apeloa PharmaceuticalLtd. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Apeloa PharmaceuticalLtd's earnings history below. Of course, the future is what really matters.
正如你所看到的,机构投资者在普洛药业股份有限公司的持股较多,这表明专业投资者们对该公司有一定的信任。但是我们不能只依赖于这一事实,因为机构有时会犯错误的投资决策,就像其他人一样。如果多个机构同时改变他们对一只股票的看法,你很可能会看到股价迅速下跌。因此,看看普洛药业股份有限公司以下的收益历史是值得的。当然,未来才是真正重要的。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240806/0-3cc84e4ff051120e141a83036df80488-1-292cfd2d15da3d80bb91cc6fb0647e40.png/big)
Hedge funds don't have many shares in Apeloa PharmaceuticalLtd. Hengdian Association of economic enterprises is currently the company's largest shareholder with 46% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 5.1% and 1.9%, of the shares outstanding, respectively.
对于普洛药业股份有限公司,对冲基金持有的股份不多。经证实,横店经济企业协会目前是该公司的最大股东,持有46%的流通股,第二和第三大的股东分别持有5.1%和1.9%的流通股。
After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.
经过进一步挖掘,我们发现前两个股东共同控制了公司50%以上的股份,说明他们有相当大的影响力来影响公司的决策。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.
尽管研究公司机构所有权数据是有意义的,但了解分析师的情绪也很有意义,以了解市场的走向。因为有很多分析师正在跟踪这个股票,所以看看他们的预测可能是值得的。
Insider Ownership Of Apeloa PharmaceuticalLtd
我发现查看一家公司的所有者非常有趣。但是要真正获得洞察力,我们需要考虑其他信息。例如,我们已经识别出普洛药业的1个警告信号,你应该知道。
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
虽然内部人员的精确定义可能具有主观性,但几乎所有人都认为董事会成员是内部人员。管理层最终向董事会负责。然而,如果经理是创始人或CEO,那么他们成为执行董事会成员并不罕见。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
当内部人持股情况表明领导层思考和公司真正所有者一样时,内部所有权是积极的。然而,高达内部人士所有权也可能为公司内的小团体带来巨大的权力。在某些情况下,这可能是负面的。
Our most recent data indicates that insiders own less than 1% of Apeloa Pharmaceutical Co.,Ltd. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. It is a pretty big company, so it would be possible for board members to own a meaningful interest in the company, without owning much of a proportional interest. In this case, they own around CN¥8.6m worth of shares (at current prices). It is good to see board members owning shares, but it might be worth checking if those insiders have been buying.
我们最近的数据表明,普洛药业股份有限公司内部人士持有不到1%的股份。但我们注意到,内部人员可能通过私营公司或其他公司结构间接拥有利益。这是一家相当大的公司,因此董事会成员可以拥有该公司相当可观的利益,而无需持有大量比例的股份。在这种情况下,他们拥有约CN¥860万的股份(以目前的价格计算)。董事会成员拥有股份是一件好事,但可能值得检查这些内部人员是否一直在购买。
General Public Ownership
一般大众所有权
The general public, who are usually individual investors, hold a 37% stake in Apeloa PharmaceuticalLtd. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
由于个人投资者持有普洛药业股份有限公司的37%,因此,这个群体可能无法决定,但肯定会对公司的运营产生实际影响。
Private Company Ownership
私有公司的所有权
It seems that Private Companies own 51%, of the Apeloa PharmaceuticalLtd stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
私人公司持有普洛药业股份有限公司的51%。这可能值得进一步研究。如果相关方,如内部人员,在其中一个私人公司中拥有权益,则应在年报中披露。私营公司可能对该公司有战略利益。
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Apeloa PharmaceuticalLtd you should know about.
我发现了解一家公司到底由谁拥有是非常有趣的。但是,要真正获得洞察力,我们还需要考虑其他信息。例如考虑风险问题,每个公司都面临着风险问题,我们已经发现了普洛药业股份有限公司的1项风险警告,你需要了解。
Ultimately the future is most important. You can access this free report on analyst forecasts for the company.
最终,未来最重要。您可以在这份关于该公司分析师预测的免费报告中获取有关信息。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。